ZENITHDRUG — Zenith Drugs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	28.9	36.1	88	2.63	2.61
Net Total Accounts Receivable
Net Total Receivables	388	566	753	726	863
Total Inventory
Total Other Current Assets
Total Current Assets	538	839	1,133	1,152	1,290
Net Property, Plant And Equipment	105	117	152	432	469
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	—	979	1,350	1,615	1,875
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	—	718	641	793	941
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	—	807	728	921	1,142
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	—	172	623	694	733
Total Liabilities & Shareholders' Equity	—	979	1,350	1,615	1,875
Total Common Shares Outstanding